Cryopharm other research news

The Pasadena, Calif., company published details on the antiviral action of its psoralen derivatives, which disrupt the nucleic acids found in all viruses, but do not harm red blood cells or platelets, which lack nuclei.

In the Proceedings of the National Academy of Sciences, company researchers and colleagues showed that tailoring the psoralens to specifically target nucleic acids, without sticking to cell membranes, should make it possible to purge blood bank materials of viruses without compromising the quality of the blood components. ...